Tempus AI TEM is slowly becoming one of the most vertically integrated data and diagnostics platforms in healthcare, bringing together genomics, multimodal real-world data and clinical AI into a ...

Two Ark Invest ETFs added Tempus AI stock to their holdings last Friday. A BTIG analyst sees significant upside to Tempus AI stock. Growth investors shouldn't dismiss Tempus AI stock solely based on ...

Shares of Tempus AI (NASDAQ: TEM), a rising star in the AI-driven healthcare sector, demonstrated strong performance this week. The stock surged 5.29% in a single day, significantly outperforming the ...

Tempus Realty Partners has announced the launch of Generational Resources and Opportunities for Well-Being, a first-of-its-kind funded savings program in Arkansas. Through GROW, Tempus will provide ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health ...

Tempus AI specializes in developing artificial intelligence solutions to improve patient outcomes in various healthcare fields. Ark Invest reduced the Tempus AI position in the ARK Innovation ETF.

Tempus AI is a Buy for long-term growth, driven by its shift to a data/AI platform and accelerating genomics volume fueling high-margin revenue. Strategic deals (AstraZeneca/Pathos) and the Paige ...

Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc ...

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday. The AI-focused precision medicine and patient care company reported a second-quarter adjusted loss of 22 cents per share, ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 medical AI companies to buy according to analysts. On July 16, the company confirmed that it had received clearance from the US Food and Drug ...

LOS ANGELES, July 31, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Tempus AI, Inc. ("Tempus" or the "Company") (NASDAQ: TEM) have opportunity ...